NIH grantwriting

Misrouting happens, but it’s often preventable. Here are some reasons why it might have happened: 1- You let CSR choose the study section. While it may be tempting to let the Center for Scientific Review’s (CSR) algorithm determine your study section assignment, that approach carries risk. The algorithm won’t invest the time and care that […]

When an applicant comes to me for advising, one of the first questions I have is about their ESI expiration, so that we can map out a long-term strategy to maximize this funding advantage, if relevant. For early-career biomedical researchers, few designations carry as much practical weight as the NIH Early Stage Investigator (ESI) status.

So you’ve invented a new health technology, and you want to commercialize it by starting a for-profit company. How do you fund this early spinout? Non-dilutive funding from the National Institutes of Health (NIH) through the Small Business Innovation Research (SBIR) program is a great way to start. Is This Post for Me? The applicants